TRV-7019 is a BBB-penetrable radioligand for brain imaging that target butyrylcholinesterase. TRV-7019 can be used for the diagnosis of an amyloid disease, multiple sclerosis, a brain tumor, or butyrylcholinesterase activity[1].
[1]. Sultan Darvesh, et al. Butyrylcholinesterase compounds and use in diseases of the nervous system. Patent WO2021026429A1.
















